NEXT Life Sciences Announces Successful Plan A™ Delivery Device Clinical Trial in Australia
NEXT Life Sciences, the modern reproductive healthcare company pioneering Plan A™, a first-of-its-kind, long-lasting, and on-demand reversible male contraceptive in development, announces the successful completion of its clinical trial in Australia with a 100% success rate.